» Articles » PMID: 37582716

Causal Role of Immune Cells in Schizophrenia: Mendelian Randomization (MR) Study

Overview
Journal BMC Psychiatry
Publisher Biomed Central
Specialty Psychiatry
Date 2023 Aug 15
PMID 37582716
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Complex immune-brain interactions that affect neural development, survival and function might have causal and therapeutic implications for psychiatric illnesses. However, previous studies examining the association between immune inflammation and schizophrenia (SCZ) have yielded inconsistent findings.

Methods: Comprehensive two-sample Mendelian randomization (MR) analysis was performed to determine the causal association between immune cell signatures and SCZ in this study. Based on publicly available genetic data, we explored causal associations between 731 immune cell signatures and SCZ risk. A total of four types of immune signatures (median fluorescence intensities (MFI), relative cell (RC), absolute cell (AC), and morphological parameters (MP)) were included. Comprehensive sensitivity analyses were used to verify the robustness, heterogeneity, and horizontal pleiotropy of the results.

Results: After FDR correction, SCZ had no statistically significant effect on immunophenotypes. It was worth mentioning some phenotypes with unadjusted low P-values, including FSC-A on NKT (β = 0.119, 95% CI = 0.044 ~ 0.194, P = 0.002), DN (CD4-CD8-) NKT %T cell (β = 0.131, 95% CI = 0.054 ~ 0.208, P = 9.03 × 10), and SSC-A on lymphocytes (β = 0.136, 95% CI = 0.059 ~ 0.213, P = 5.43 × 10). The causal effect of SCZ IgD on transitional was estimated to 0.127 (95% CI = 0.051 ~ 0.203, P = 1.09 × 10). SCZ also had a causal effect on IgD+ %B cell (β = 0.130, 95% CI = 0.054 ~ 0.207, P = 8.69 × 10), and DP (CD4CD8) %T cell (β = 0.131, 95% CI = 0.054 ~ 0.207, P = 8.05 × 10). Furthermore, four immunophenotypes were identified to be significantly associated with SCZ risk: naive CD4 %T cell (OR = 0.986, 95% CI = 0.979 ~ 0.992, P = 1.37 × 10), HLA DR on CD14 CD16 (OR = 0.738 (95% CI = 0.642 ~ 0.849, P = 2.00 × 10), CD33 HLA DR CD11b AC (OR = 0.631, 95% CI = 0.529 ~ 0.753, P = 3.40 × 10) and activated & resting Treg % CD4 Treg (OR = 0.937, 95% CI = 0.906 ~ 0.970, P = 1.96 × 10).

Conclusions: Our study has demonstrated the close connection between immune cells and SCZ by genetic means, thus providing guidance for future clinical research.

Citing Articles

Causal relationship between Baff-R expression and normal pressure hydrocephalus: insights from Mendelian randomization analysis.

Wang W, Ma L, Liu M, Zhao Y, Ye W, Li X BMC Neurol. 2025; 25(1):98.

PMID: 40055671 PMC: 11889935. DOI: 10.1186/s12883-025-04098-4.


Causality of blood metabolites on hepatocellular carcinoma and cholangiocarcinoma: a metabolome-wide mendelian randomization study.

Ning L, Gao Z, Chen D, Han J, Xie G, Sun J BMC Cancer. 2025; 25(1):389.

PMID: 40038628 PMC: 11877886. DOI: 10.1186/s12885-025-13690-3.


Role of Immune Cells in Mediating the Effect of Lipids on Preeclampsia.

Dang C, Duan Y, Liu P, Liu J, Yu X, Wang J Reprod Sci. 2025; .

PMID: 40019643 DOI: 10.1007/s43032-025-01809-7.


Screening and Validation of Potential Biomarkers of Immune Cells in Childhood Asthma Patients via Mendelian Randomization and Machine Learning.

Zhang Y, Hai Y, Song B, Xu J, Cao L, Yasen R J Inflamm Res. 2025; 18:2583-2600.

PMID: 40008080 PMC: 11853831. DOI: 10.2147/JIR.S498017.


Assessing the causal association between 731 immunophenotypes and the risk of colorectal cancer: a Mendelian randomization study.

Gao F, Zhang Q, Teng F, Li L, Jiang H, Li W BMC Cancer. 2025; 25(1):335.

PMID: 40001057 PMC: 11854232. DOI: 10.1186/s12885-025-13701-3.


References
1.
Khandaker G, Pearson R, Zammit S, Lewis G, Jones P . Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry. 2014; 71(10):1121-8. PMC: 4561502. DOI: 10.1001/jamapsychiatry.2014.1332. View

2.
Jauhar S, Johnstone M, McKenna P . Schizophrenia. Lancet. 2022; 399(10323):473-486. DOI: 10.1016/S0140-6736(21)01730-X. View

3.
Charlson F, Ferrari A, Santomauro D, Diminic S, Stockings E, Scott J . Global Epidemiology and Burden of Schizophrenia: Findings From the Global Burden of Disease Study 2016. Schizophr Bull. 2018; 44(6):1195-1203. PMC: 6192504. DOI: 10.1093/schbul/sby058. View

4.
Mueser K, McGurk S . Schizophrenia. Lancet. 2004; 363(9426):2063-72. DOI: 10.1016/S0140-6736(04)16458-1. View

5.
Lieberman J, Small S, Girgis R . Early Detection and Preventive Intervention in Schizophrenia: From Fantasy to Reality. Am J Psychiatry. 2019; 176(10):794-810. DOI: 10.1176/appi.ajp.2019.19080865. View